|
|
Volumn 32, Issue 19, 2014, Pages 2217-2224
|
|
Phase 3 trial evaluating the immunogenicity and safety of a three-dose BioThrax® regimen for post-exposure prophylaxis in healthy adults
a
|
|
Author keywords
Anthrax; Clinical trial; Immunogenicity; Post exposure prophylaxis; Vaccine
|
|
Indexed keywords
ANTHRAX VACCINE;
NEUTRALIZING ANTIBODY;
TOXIN NEUTRALIZING ANTIBODY;
UNCLASSIFIED DRUG;
ABDOMINAL PAIN;
ACNE;
ADULT;
AGED;
ARTHRALGIA;
ARTICLE;
BACKACHE;
BENIGN TUMOR;
BRONCHITIS;
CELLULITIS;
CONNECTIVE TISSUE DISEASE;
CONTACT DERMATITIS;
CONTROLLED STUDY;
COUGHING;
DECREASED APPETITE;
DENTAL CARIES;
DIARRHEA;
DIZZINESS;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
DRUG TOLERABILITY;
DRY SKIN;
DYSPEPSIA;
EAR DISEASE;
ECZEMA;
EVALUATION STUDY;
EXTERNAL OTITIS;
EYE DISEASE;
FACE EDEMA;
FACE PAIN;
FATIGUE;
FEMALE;
FEVER;
GASTRITIS;
GASTROENTERITIS;
GASTROINTESTINAL DISEASE;
GINGIVITIS;
HEADACHE;
HEMATOMA;
HERPETIC STOMATITIS;
HUMAN;
HUMAN EXPERIMENT;
HYPERPIGMENTATION;
HYPERTENSION;
HYPESTHESIA;
IMMUNOGENICITY;
IMMUNOPATHOLOGY;
INFECTION;
INFESTATION;
INJECTION SITE CONTUSION;
INJECTION SITE DISCOLORATION;
INJECTION SITE MASS;
INJECTION SITE PAIN;
INJECTION SITE PRURITUS;
INJECTION SITE REACTION;
INJECTION SITE SWELLING;
INJECTION SITE WARMTH;
INNER EAR DISEASE;
INSOMNIA;
IRRITABLE COLON;
JOINT STIFFNESS;
LIMB INJURY;
MACULOPAPULAR RASH;
MALE;
MENTAL DISEASE;
METABOLIC DISORDER;
MIDDLE AGED;
MOTION SICKNESS;
MULTICENTER STUDY;
MUSCLE STRAIN;
MYALGIA;
NAUSEA;
NECK PAIN;
NORMAL HUMAN;
NOSE OBSTRUCTION;
NUTRITIONAL DISORDER;
OBESITY;
OROPHARYNX PAIN;
OTITIS MEDIA;
PATIENT COMPLIANCE;
PERIPHERAL EDEMA;
PHARYNGITIS;
PHASE 3 CLINICAL TRIAL;
PHYSICAL EXAMINATION;
POST EXPOSURE PROPHYLAXIS;
PRESYNCOPE;
PRIORITY JOURNAL;
PRURITUS;
RABBIT;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY TRACT INFECTION;
RHINITIS;
RHINOPHARYNGITIS;
RHINORRHEA;
SCROTAL PAIN;
SIDE EFFECT;
SINUS CONGESTION;
SINUS HEADACHE;
SKIN ABSCESS;
SKIN CYST;
SKIN INFECTION;
SLEEP DISORDER;
STREPTOCOCCAL PHARYNGITIS;
TENSION HEADACHE;
TONSILLITIS;
TOOTH ABSCESS;
TOOTH FRACTURE;
TOOTH INFECTION;
TOOTH PAIN;
UPPER RESPIRATORY TRACT INFECTION;
URINARY TRACT INFECTION;
VACCINATION;
VAGINA BLEEDING;
VAGINITIS;
VASCULAR DISEASE;
VIRUS INFECTION;
VITAL SIGN;
VOMITING;
YOUNG ADULT;
ANTHRAX;
BIOTHRAX(®);
CLINICAL TRIAL;
IMMUNOGENICITY;
POST-EXPOSURE PROPHYLAXIS;
VACCINE;
ADOLESCENT;
ADULT;
AGED;
ANTHRAX;
ANTHRAX VACCINES;
ANTIBODIES, BACTERIAL;
ANTIBODIES, NEUTRALIZING;
FEMALE;
HEALTHY VOLUNTEERS;
HUMANS;
IMMUNIZATION, SECONDARY;
MALE;
MIDDLE AGED;
POST-EXPOSURE PROPHYLAXIS;
YOUNG ADULT;
|
|
EID: 84897110883
PISSN: 0264410X
EISSN: 18732518
Source Type: Journal
DOI: 10.1016/j.vaccine.2014.01.073 Document Type: Article |
|
Times cited : (18)
|
|
References (11)
|
